Olink Holding AB (publ)
OLK
Rank in Stocks
#4810
Olink Holding AB (publ) offers a comprehensive suite of products and services... Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical companies, and biotechnology firms. The company's product lines include Olink Explore, which is designed to aid research in critical areas such as cardiovascular and metabolic health, oncology, neurology, and inflammation. Additionally, it features the Olink Target product line and the Olink Focus product line, the latter providing bespoke solutions for clients who have already pinpointed specific proteins or protein signatures for their studies. Beyond these, Olink supplies the Signature Q100, a dedicated platform for qPCR (quantitative Polymerase Chain Reaction) readouts. Its service portfolio encompasses Olink Analysis, offering end-to-end support from study design and expert consultation to sample preparation, assay execution, and stringent quality control of data, complemented by bioinformatics services. For data management and analysis, Olink provides the normalized protein expression (NPX) Manager, a specialized software tool enabling users to import data, validate its quality, and normalize findings in preparation for statistical analysis. Furthermore, Olink Insight serves as a cloud-based platform for visualizing and statistically analyzing NPX data. Olink Holding AB (publ) markets and sells its offerings worldwide through its proprietary direct sales force, reaching customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Established in 2004 and based in Uppsala, Sweden, the company underwent a name change in January 2021 from its former identity, Knilo HoldCo AB, to its current designation. It operates as a subsidiary of Summa Equity Holding AB.
Share Price
$26.08
Last synced: 2024-07-09
Market Cap
$3.10B
Change (1 day)
0.31%
Change (1 year)
0.00%
Country
SE
Trade Olink Holding AB (publ) (OLK)
Category
Healthcare
Revenue for Olink Holding AB (publ) (OLK)
Revenue in Mar 2024 TTM: $171.45M
According to Olink Holding AB (publ) latest financial reports the company's current revenue (TTM) is $171.45M. In 2022 the company made a revenue of $139.85M an increase over the revenue in the year 2021 that was $94.97M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Olink Holding AB (publ) from 2019 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $171.45M | 0.91% |
| 2023 | $169.91M | 21.49% |
| 2022 | $139.85M | 47.25% |
| 2021 | $94.97M | 75.66% |
| 2020 | $54.07M | 29.68% |
| 2019 | $41.69M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $46.34B | 26,926.59% |
US
|
|
| $25.11B | 14,544.26% |
US
|
|
| $2.71B | 1,478.97% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 4,199.90% |
US
|
